Frailty and aging with HIV in West Africa

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study compares older adults (60+) with and without HIV across multiple West African sites to describe frailty and geriatric syndromes. It uses a mixed-methods approach, including clinical assessments, questionnaires, and qualitative interviews with patients, families, and caregivers. The study collects data on comorbidities, functional status, and care pathways, and applies descriptive and multivariate analyses to identify factors associated with frailty. Findings aim to inform screening, diagnosis, and management of aging-related conditions in this population.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* HIV+ Group

  * Person 60 years of age and older
  * Infected with HIV-1 and/or 2
  * Able to move around the data collection site
  * Having given free and informed consent
* HIV- Group

  * Person 60 years of age and older
  * HIV-uninfected
  * Able to move around the data collection site
  * Having given free and informed consent

Exclusion Criteria:

Person deprived of liberty (guardianship, curatorship, judicial safeguard) Karnofsky Index 50≤50% Hospitalized

\-

Where it's running

• Centre de Prise en Charge de Formation et de Recherche (CEPREF)
  Yopougon, Abidjan Autonomous District, Côte d’Ivoire Recruiting
• Hôpital de jour du CHU Sourou Sanou
  Bobo-Dioulasso, Burkina Faso Not yet recruiting
• Centre Médical de Suivi des donneurs de sang (CMSDS)
  Treichville, Abidjan Autonomous District, Côte d’Ivoire Not yet recruiting
• Service des Maladies Infectieuses et Tropicales (SMIT)
  Treichville, Abidjan Autonomous District, Côte d’Ivoire Not yet recruiting
• ONG Espoir Vie Togo
  Lomé, Togo Not yet recruiting
• Service des Maladies Infectieuses et Tropicales-CHU Sylvanus Olympio
  Lomé, Togo Not yet recruiting

Study contacts

• Principal investigator: Clotilde ALLAVENA — Nantes University Hospital
• Study coordinator: Fifonsi GBEASOR-KOMLANVI
• Email: fifonsi.gbeasor@gmail.com
• Phone: +228 93 87 41 55

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• booster vaccines for adults previously vaccinated against COVID-19

  This trial tests two new vaccine boosters against the two approved boosters in healthy adults aged 18–65 who previously received mRNA vaccines.

  Recruiting at 3 sites Early Phase 1 ANRS, Emerging Infectious Diseases · Créteil and 2 other locations · NCT07605520

• HBV Universal vs Point-of-Ccare Antiviral Prophylaxis to Prevent Mother-to-Child Transmission

  This trial tests whether giving antiviral prophylaxis to all HBsAg-positive pregnant women is as effective as a selective approach guided by a rapid HBcrAg test in preventing mother-to-child transmission of hepatitis B.

  Recruiting ANRS, Emerging Infectious Diseases · Haiphong · NCT07054359

• Tuberculosis treatment pathways and outcomes in France: a national cohort

  This French national cohort follows adults starting tuberculosis treatment to see how sociodemographic, clinical, and biological factors relate to treatment outcomes and relapse over 24 months.

  Recruiting ANRS, Emerging Infectious Diseases · Paris and 1 other locations · NCT06893757

• Comparing an intranasal COVID-19 vaccine to an mRNA booster in healthy adults

  This study is testing a new intranasal COVID-19 vaccine to see if it works as well as a standard mRNA booster in healthy adults.

  Recruiting Phase 1/2 ANRS, Emerging Infectious Diseases · Dijon and 4 other locations · NCT06821126

• HPV molecular patterns linked to high-grade anal lesions and cancer in former IPERGAY participants

  This project will test whether specific HPV molecular signatures predict high-grade anal lesions or anal cancer in people who were part of the IPERGAY HPV substudy about 10 years earlier.

  Recruiting at 3 sites ANRS, Emerging Infectious Diseases · Lyon and 2 other locations · NCT06522256

• Testing a new COVID-19 vaccine booster for safety and immune response

  This study is testing a new COVID-19 vaccine booster to see if it’s safe and helps healthy people build a strong immune response compared to an approved vaccine.

  Recruiting at 2 sites Phase 1/2 ANRS, Emerging Infectious Diseases · Créteil and 1 other locations · NCT06255626

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.